Arthrose

Code/s CIM-10 : M15;M16;M17;M18;M19
Auteur : Article non édité
Dernière mise à jour : 30/11/-0001

A éditer.

Causes : A éditer

Anti-diabetiques - Analogues GLP-1 : Liraglutide, Dulaglutide, Sémaglutide …

Chez les patients obèses

En cas d'obésité clinique sans perte de poids suffissante avec l'éducation à la nutrition et exercise

Recos Arthrose USA 2026. Recommandations de pratique clinique : 2026 Update of the American College of Rheumatology Recommendations for the Management of Osteoarthritis of the Knee, Hip, and Hand

Key Recommendations: a) Enhancing self-efficacy and self-management. b) Participating in exercise. c) Pursuing weight loss when appropriate. d) Using topical and oral nonsteroidal anti-inflammatory drugs (NSAIDs), when clinically appropriate. e) Considering intraarticular glucocorticoid injections. .. introduces two notable conditional recommendations: a) GLP-1 receptor agonists may be considered to help people with knee OA achieve an optimal weight ... b) Methotrexate may be considered for people with eros
Wattanasirisombat 2026. Essai randomisé en double insu : Betamethasone and Triamcinolone Acetonide Have Comparable Efficacy as Single Intra-Articular Injections in Knee Osteoarthritis: A Double-Blinded, Randomized Controlled Trial. J Bone Joint Surg Am

120 patients with symptomatic knee OA who were randomized to receive either a betamethasone (7-mg) or triamcinolone acetonide (40-mg) IA injection and were followed for 6 months. .. Both the betamethasone and triamcinolone groups demonstrated significant reductions in VAS pain at rest starting from day 1 and lasting for up to 6 months. .. No significant differences were observed between IA betamethasone and triamcinolone acetonide with respect to VAS pain, functional scores, or performance-based outcomes